Evidence map›Paper›PMID 29351055›Full record

ArticleHuman vaccines & immunotherapeutics2018

Are pre-terms born timely and right immunized? Results of an Italian cohort study.

Nicola Laforgia, Antonio Di Mauro, Francesco Paolo Bianchi, Federica Di Mauro, Andrea Zizzi, Manuela Capozza, Silvia Intini, Maria Serena Gallone, Silvio Tafuri

Open access · hybridAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nicola Laforgiaa Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Antonio Di Mauroa Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Francesco Paolo Bianchia Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Federica Di Mauroa Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Andrea Zizzia Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Manuela Capozzaa Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Silvia Intinia Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Maria Serena Gallonea Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Silvio Tafuria Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to evaluate the vaccination coverage at 24 months of chronological age in a sample of preterm infants discharged by the Neonatal Intensive Care Unit (NICU) of the Bari Policlinico University General Hospital in Italy. The list of infants preterm born discharged during 2013 by the NICU was obtained by hospital database. Vaccination status of each subject at 24 months of chronological age was acquired by the Apulian Regional Vaccination Register (GIAVA). 159 preterm borns were enrolled in this study. 98.1% received the 1st dose of hexavalent vaccine and 98.7% the 1st dose of pneumococcal conjugate vaccine. The 8.8% of hexavalent vaccinations were performed during hospitalization. The percentage of immunized subjects decreased to 91.2% and 87.3% for the 2nd and 3rd dose of hexavalent vaccine and to 90.6% and 86.1% for the 2nd and 3rd dose of pneumococcal conjugate vaccine. Coverage for MMR, MEN C and Varicella vaccines were, respectively 76.4%, 86.0% and 80.9%. Pre-terms received the vaccinations later than the age recommended by public health guidelines. Age at the immunization, for all vaccines, seems to increase for lower gestational age and birth weight and for higher length of hospitalization. This study shows a high risk of vaccine delay among pre-terms born. There is a strong need to improve specific vaccination strategies for this group. Neonatologists might play a key role in informing parents about the vaccination schedule at the moment of NICU discharge and during follow-up, also preparing correct time schedule.

Indexed as

Infant, PrematureVaccination CoverageCohort StudiesFemaleHumansInfant, NewbornItalyMaleVaccinesVaccineshigh risk groupsneonatologistsvaccination complianceVaccination delayvaccine coverage

Identifiers

PMID29351055
PMCPMC6037452
OpenAlexW2788050794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.